Dermatol. praxi. 2011;5(2):98-102

UV phototherapy

MUDr.Jana Bernardová
Dermatovenerologická klinika 2. LF UK a FN Na Bulovce, Praha

This article briefly discusses the form of ultraviolet light phototherapy in dermatology – includes the preparation before starting therapy,

indications and contraindications to this treatment and its implementation.

Keywords: phototherapy, minimal erythemal dose, UVA, UVB, PUVA

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bernardová J. UV phototherapy. Dermatol. praxi. 2011;5(2):98-102.
Download citation

References

  1. Holzle E, Honigsmann H, Rocken M et al. Recommendations for phototherapy and photochemotherapy. J Dtsch Dermatol Ges 2003; 1: 985-997. Go to original source... Go to PubMed...
  2. Ettler K. Stanovení minimálních erytémových dávek a přirozené fotoprotekce kůže u naší populace. Acta medica, suppl. 1998; 1: 81-104.
  3. Ettler K. Foto (chemo) terapie v dermatologické léčbě. Čs Derm, 2005; 80: 5.
  4. Honigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol 2001; 26: 343-350. Go to original source... Go to PubMed...
  5. Young A. Carcinogenity of UVB phototherapy assessed. Lancet 1995; 345: 1431-1432. Go to original source...
  6. Storbeck K, Hölzle E, Lehmann P, et al. Die Wirksamkeit eines neuen Schmalspektrum-UVB Strahlers im Vergleich zur konventionellen UVB Phototerapie der Psoriasis. Z Hautkr 1991; 66: 708-712.
  7. Bilsland D, Dawe R, Diffey BL, et al. An appraisal of narrowband UV-B phototherapy. British Photodermatology Group Workshop report (April 1996). Br J Dermatol 1997; 137: 327-330. Go to original source...
  8. Ohtsuka T. Narrowband UVB phototherapy for early-stage mycosis fungoides. EJD, 2004; 18(4): 464-466.
  9. Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis. JEADV 2009; 23(Suppl. 2): 1-70. Go to original source... Go to PubMed...
  10. Hadshiew I. Therapieprinzipen in der Dermatologie. Dermatologie, Moll I. Thieme, 2005; 48-63.
  11. Dawe RS, Krönauer C, Eberlein-König B, Ring J, et al. Influence of UVB, UVA and UVA1 irradiation on histamine release from human basophils and mast cells in vitro in the presence and absence of antioxidants. Photochem Photobiol 2003; 77: 531-534. Go to original source...
  12. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003; 148: 626-637. Go to original source... Go to PubMed...
  13. Simon JC, Pfieger D, Schöpf E. Recent advances in phototherapy. Eur J Dermatol 2000; 10: 642-645.
  14. Rombold S, Lobisch K, Karzer K, et al. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatology, photoimunology and photomedicine 2008; 24: 19-23. Go to original source... Go to PubMed...
  15. Honigsman H, Schwarz T. Ultraviolet Therapy. Bologna JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Elsevier ltd., 2008: 2053-2069.
  16. Benáková N, Ettler K. Fototerapie v České republice. Česslov Derm 2010; 85(3): 139-147.
  17. Tanew A, Radakovic-Fijan S, Schemper M, et al. Narrowband UVB phototherapy vs. photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol. 1999; 135: 519-524. Go to original source... Go to PubMed...
  18. Lebwohl M, Drake L, Menter A, et al. Concensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol 2001; 45(4): 544-553. Go to original source... Go to PubMed...
  19. Mahajan R, Kaur I, Kanwar AJ. Methotrexate/narrowband UVB phototherapy combination vs. Narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis - a randomized single-blinded placebo-controlled study. JEADV 2010; 24: 595-600. Go to original source... Go to PubMed...
  20. Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. J Am Acad Dermatol 2006; 54: 1013-1018. Go to original source... Go to PubMed...
  21. Hofer A, Hassan AS, Legat FJ, et al. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol. 2005; 152: 981-985. Go to original source... Go to PubMed...
  22. Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. J Europ Acad Dermatol Ven, 2003; 17(2): 171-177. Go to original source... Go to PubMed...
  23. Hercogová J, Buggiani G, Prignano F, Lotii T. A rational approach to the treatment of vitiligo and another hypomelanoses. Dermatol Clin, 2007; 25(3): 383-392. Go to original source... Go to PubMed...
  24. Lotti T, Buggiani G, Troiano M, Assad GB, Delescluse J, De Giorgi V, Hercogova J. Targeted and combination treatments for vitiligo - Comparative evaluation of different current modalities in 458 subjects. Dermatol Therapy 2008; 26: S20-S26. Go to original source... Go to PubMed...
  25. Sator PG, Radakovic S, Schulmeister K, Hönigsmann H, Tanew A. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol. May 2009; 60(5): 786-791. Go to original source... Go to PubMed...
  26. Kreuter A, Hyun J, Stücker M, et al. A randomized controlled study of low-dose UVA1, medium dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006; 54: 440-447. Go to original source... Go to PubMed...
  27. Dittmar HC, Pflieger D, Schöpf E, et al. UVA1-Phototerapie: Pilotstudie zur Dosisfindung bei der akut exazerbierten atopischen Dermatitis. Hautarzt 2001; 52: 423-427. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.